Strontium ranelate reduces the progression of experimental dog osteoarthritis by inhibiting the expression of key proteases in cartilage and of IL-1β in the synovium. (Q50501926)
Jump to navigation
Jump to search
scientific article published on 13 October 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Strontium ranelate reduces the progression of experimental dog osteoarthritis by inhibiting the expression of key proteases in cartilage and of IL-1β in the synovium. |
scientific article published on 13 October 2012 |
Statements
1 reference
Strontium ranelate reduces the progression of experimental dog osteoarthritis by inhibiting the expression of key proteases in cartilage and of IL-1β in the synovium. (English)
1 reference
Johanne Martel-Pelletier
1 reference
Jean-Pierre Pelletier
1 reference
Hassan Fahmi
1 reference
Daniel Lajeunesse
1 reference
Mohit Kapoor
1 reference
Alexia Blesius
1 reference
Juliette Maillet
1 reference
13 October 2012
1 reference
72
1 reference
250-257
1 reference
2
1 reference
Identifiers
1 reference